Kaidor

Citalopram Hydrochloride, the active ingredient in Kaidor, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet (strength not specified) for oral use. It treats major depressive disorder, panic disorder, and obsessive‑compulsive disorder in adult patients.

GNH USA supplies Kaidor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Citalopram, an SSRI, is used to manage conditions linked to serotonin imbalance.

Major depressive disorder: alleviates depressive symptoms and improves mood. Panic disorder: reduces frequency and intensity of panic attacks. Obsessive‑compulsive disorder: diminishes obsessive thoughts and compulsive behaviors.

Citalopram may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or throbbing pain. - Dry mouth: reduced salivation. - Insomnia or somnolence: sleep disturbances. - Sexual dysfunction: decreased libido or delayed orgasm. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, tremor. - QT interval prolongation: cardiac rhythm changes. - Severe hyponatremia: low blood sodium levels. - Suicidal ideation: emergent thoughts of self‑harm. - Allergic reactions: rash, swelling, or anaphylaxis.

Before prescribing citalopram, clinicians should consider several safety aspects.

Pregnancy: assess risk‑benefit, as safety data are limited. Elderly patients: monitor for hyponatremia and falls. Concomitant QT‑prolonging drugs: avoid additive cardiac risk. History of bipolar disorder: watch for mood switching. Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Citalopram can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Pimozide: increased plasma levels, cardiac toxicity. - Certain antiarrhythmics (e.g., quinidine): QT prolongation.

Moderate Interactions (Monitor Closely): - NSAIDs or anticoagulants: heightened bleeding risk. - CYP2C19 inhibitors (e.g., fluoxetine): elevated citalopram concentrations. - Diuretics: potential for hyponatremia. - Alcohol: may worsen CNS depression. - Other serotonergic agents (e.g., tramadol): monitor for serotonin syndrome.